EHS
EHS

CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia | BMC Gastroenterology


  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

    PubMed 

    Google Scholar
     

  • Maconi G, Manes G, Porro GB. Role of symptoms in diagnosis and outcome of gastric cancer. World J Gastroenterol. 2008;14(8):1149–55.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zheng L, Wu C, Xi P, Zhu M, Zhang L, Chen S, et al. The survival and the long-term trends of patients with gastric cancer in Shanghai, China. BMC Cancer. 2014;14:300.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26–38.

    CAS 
    PubMed 

    Google Scholar
     

  • Matsuda T, Ajiki W, Marugame T, Ioka A, Tsukuma H, Sobue T, et al. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol. 2011;41(1):40–51.

    Article 
    PubMed 

    Google Scholar
     

  • Jung KW, Won YJ, Kong HJ, Lee ES. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016. Cancer Res Treat. 2019;51(2):417–30.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Park JM, Kim YH. Current approaches to gastric cancer in Korea. Gastrointest Cancer Res. 2008;2(3):137–44.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I, et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer. 2011;14(4):301–16.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48(13):3554–60.

    CAS 
    PubMed 

    Google Scholar
     

  • Rokkas T, Rokka A, Portincasa P. A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer. Ann Gastroenterol. 2017;30(4):414–23.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen HN, Wang Z, Li X, Zhou ZG. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Gastric Cancer. 2016;19(1):166–75.

    Article 
    PubMed 

    Google Scholar
     

  • Marques-Silva L, Areia M, Elvas L, Dinis-Ribeiro M. Prevalence of gastric precancerous conditions: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2014;26(4):378–87.

    Article 
    PubMed 

    Google Scholar
     

  • Song H, Ekheden IG, Zheng Z, Ericsson J, Nyren O, Ye W. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015;351:h3867.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jass JR, Filipe MI. A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study. Histopathology. 1979;3(3):191–9.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Filipe MI, Potet F, Bogomoletz WV, Dawson PA, Fabiani B, Chauveinc P, et al. Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut. 1985;26(12):1319–26.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gonzalez CA, Sanz-Anquela JM, Companioni O, Bonet C, Berdasco M, Lopez C, et al. Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study. J Gastroenterol Hepatol. 2016;31(5):953–8.

    Article 
    PubMed 

    Google Scholar
     

  • Shao L, Li P, Ye J, Chen J, Han Y, Cai J, et al. Risk of gastric cancer among patients with gastric intestinal metaplasia. Int J Cancer. 2018;143(7):1671–7.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M, et al. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019;68(9):1545–75.

    Article 
    PubMed 

    Google Scholar
     

  • Pimentel-Nunes P, Libanio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365–88.

    Article 
    PubMed 

    Google Scholar
     

  • Lloyd JM, Owens SR. CD10 immunohistochemistry stains enteric mucosa, but negative staining is unreliable in the setting of active enteritis. Mod Pathol. 2011;24(12):1627–32.

    Article 
    PubMed 

    Google Scholar
     

  • Das KM, Prasad I, Garla S, Amenta PS. Detection of a shared colon epithelial epitope on Barrett epithelium by a novel monoclonal antibody. Ann Intern Med. 1994;120(9):753–6.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Mirza ZK, Das KK, Slate J, Mapitigama RN, Amenta PS, Griffel LH, et al. Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma. Gut. 2003;52(6):807–12.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Das KM, Sakamaki S, Vecchi M, Diamond B. The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody. J Immunol. 1987;139(1):77–84.

    CAS 
    PubMed 

    Google Scholar
     

  • Busuttil RA, George J, Tothill RW, Ioculano K, Kowalczyk A, Mitchell C, et al. A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal response. Clin Cancer Res. 2014;20(10):2761–72.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462(7269):108–12.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang M, Huang YK, Kong JC, Sun Y, Tantalo DG, Yeang HXA, et al. High-dimensional analyses reveal a distinct role of T-cell subsets in the immune microenvironment of gastric cancer. Clin Transl Immunol. 2020;9(5):e1127.

    CAS 

    Google Scholar
     

  • Ikeda Y, Nishikura K, Watanabe H, Watanabe G, Ajioka Y, Hatakeyama K. Histopathological differences in the development of small intestinal metaplasia between antrum and body of stomach. Pathol Res Pract. 2005;201(7):487–96.

    Article 
    PubMed 

    Google Scholar
     

  • Niwa T, Ikehara Y, Nakanishi H, Tanaka H, Inada K, Tsukamoto T, et al. Mixed gastric- and intestinal-type metaplasia is formed by cells with dual intestinal and gastric differentiation. J Histochem Cytochem. 2005;53(1):75–85.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Kawachi T, Kurisu M, Numanyu N, Sasajima K, Sano T. Precancerous changes in the stomach. Cancer Res. 1976;36(7 PT 2):2673–7.

    CAS 
    PubMed 

    Google Scholar
     

  • Liu Q, Teh M, Ito K, Shah N, Ito Y, Yeoh KG. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer. Mod Pathol. 2007;20(12):1286–97.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Zhao H, Wen J, Dong X, He R, Gao C, Zhang W, et al. Identification of AQP3 and CD24 as biomarkers for carcinogenesis of gastric intestinal metaplasia. Oncotarget. 2017;8(38):63382–91.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gremel G, Wanders A, Cedernaes J, Fagerberg L, Hallstrom B, Edlund K, et al. The human gastrointestinal tract-specific transcriptome and proteome as defined by RNA sequencing and antibody-based profiling. J Gastroenterol. 2015;50(1):46–57.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer. 2003;3(8):592–600.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545–51.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Aran D, Camarda R, Odegaard J, Paik H, Oskotsky B, Krings G, et al. Comprehensive analysis of normal adjacent to tumor transcriptomes. Nat Commun. 2017;8(1):1077.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • de Assumpcao PP, Khayat AS, Thomaz Araujo TM, Barra WF, Ishak G, Cruz Ramos AMP, et al. Traps and trumps from adjacent-to-tumor samples in gastric cancer research. Chin J Cancer Res. 2018;30(5):564–7.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Companioni Napoles O, Tsao AC, Sanz-Anquela JM, Sala N, Bonet C, Pardo ML, et al. SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer. J Gastroenterol. 2017;52(1):39–49.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Svensson M, Agace WW. Role of CCL25/CCR9 in immune homeostasis and disease. Expert Rev Clin Immunol. 2006;2(5):759–73.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Han Y, Lu S, Wen YG, Yu FD, Zhu XW, Qiu GQ, et al. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer. Eur J Cell Biol. 2015;94(12):642–52.

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Song C, Han Y, Luo H, Qin Z, Chen Z, Liu Y, et al. HOXA10 induces BCL2 expression, inhibits apoptosis, and promotes cell proliferation in gastric cancer. Cancer Med. 2019;8(12):5651–61.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen W, Wu G, Zhu Y, Zhang W, Zhang H, Zhou Y, et al. HOXA10 deteriorates gastric cancer through activating JAK1/STAT3 signaling pathway. Cancer Manag Res. 2019;11:6625–35.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • He YX, Song XH, Zhao ZY, Zhao H. HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition. Eur Rev Med Pharmacol Sci. 2017;21(2):258–65.

    PubMed 

    Google Scholar
     

  • Hibi K, Kitamura YH, Mizukami H, Goto T, Sakuraba K, Sakata M, et al. Frequent CDH3 demethylation in advanced gastric carcinoma. Anticancer Res. 2009;29(10):3945–7.

    CAS 
    PubMed 

    Google Scholar
     

  • Eftang LL, Esbensen Y, Tannaes TM, Blom GP, Bukholm IR, Bukholm G. Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival. BMC Cancer. 2013;13:586.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Fu H, Ma Y, Yang M, Zhang C, Huang H, Xia Y, et al. Persisting and increasing neutrophil infiltration associates with gastric carcinogenesis and E-cadherin downregulation. Sci Rep. 2016;6:29762.

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315–6.

    Article 
    PubMed 

    Google Scholar
     

  • Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010;71(7):1150–8.

    Article 
    PubMed 

    Google Scholar
     

  • Jang BG, Lee BL, Kim WH. Intestinal stem cell markers in the intestinal metaplasia of stomach and Barrett’s esophagus. PLoS ONE. 2015;10(5):e0127300.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Watari J, Das KK, Amenta PS, Tanabe H, Tanaka A, Geng X, et al. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia. Clin Gastroenterol Hepatol. 2008;6(4):409–17.

    Article 
    PubMed 

    Google Scholar
     

  • Feng XS, Wang YF, Hao SG, Ru Y, Gao SG, Wang LD. Expression of Das-1, Ki67 and sulfuric proteins in gastric cardia adenocarcinoma and intestinal metaplasia lesions. Exp Ther Med. 2013;5(6):1555–8.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     



  • Source link

    EHS
    Back to top button